GOLDMAN SACHS GROUP INC (GS) Stock News

The article compares two Vanguard short-term bond ETFs: VGSH (Treasury ETF) and VCSH (Corporate Bond ETF). Both charge 0.03% expense ratios, but VCSH offers higher yield (4.56%) with more volatility, while VGSH provides lower risk with 3.78% yield. The author recommends VGSH for current economic conditions due to recession concerns and elevated interest rates, suggesting VCSH is better suited for purchasing during economic downturns.

Figs (FIGS) shares rose 6.5% to $14.98 on strong volume, supported by positive earnings expectations of $0.07 per share (+40% YoY) and revenue growth of 19.5%. The company benefits from strong customer engagement, product innovation, and expanding international operations. Earnings estimate revisions have been revised 1.2% higher over the past month, suggesting continued momentum. The stock carries a Zacks Rank #2 (Buy) rating.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Celsius Holdings, Inc. and other companies. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased securities during the specified class periods may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Papa John's International (PZZA) on behalf of investors who purchased stock between August 7, 2025 and August 5, 2026. The lawsuit alleges that Papa John's made materially false and misleading statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, requiring a shift toward increased promotional efforts.

PagSeguro Digital Ltd. (PAGS) declined 2.1% to $10.72 on October 6, 2026, underperforming broader market gains. Despite a 12.54% monthly gain, the stock faces headwinds with a slight 1.05% downward revision in consensus EPS estimates over the past month. The company holds a Zacks Rank #3 (Hold) rating, though it trades at a discount valuation with a Forward P/E of 6.64 versus the industry average of 14.59.

PagSeguro Digital shares jumped 21.4% to $10.95 on strong volume, driven by its integrated fintech platform and positive sentiment from Brazil's presidential election outcome. However, earnings estimate revisions have declined 4.3% over the past 30 days, suggesting caution about sustained momentum. The company carries a Zacks Rank #3 (Hold) rating.

Goldman Sachs is expected to report Q3 2026 earnings on October 13 with consensus estimates of $13.89 EPS (up 13.4% YoY) and $16.91B in revenues (up 11.4% YoY). However, recent analyst revisions have turned bearish, resulting in a negative Earnings ESP of -11.16%, making an earnings beat unlikely despite the stock's Zacks Rank #3 rating. The company has a strong history of beating estimates, having exceeded consensus four consecutive quarters.

Zacks Equity Research analysts featured four retail stocks in their blog. Victoria's Secret remains confident in China as its top international growth driver despite moderating international growth. FIGS, Fossil Group, and Boot Barn are highlighted as better-ranked alternatives with varying growth prospects in their respective sectors.

Zacks.com released analyst research reports on five stocks on October 6, 2026. Texas Instruments and Marvell Technology showed strong outperformance driven by demand in industrial, data center, and AI sectors. RTX benefited from aerospace recovery and defense demand. Air T showed improvement in aviation services, while GSI Technology faced headwinds in commercialization despite potential in AI processing applications.

Rosen Law Firm has filed securities class action lawsuits against Taboola.com Ltd., The Simply Good Foods Company, and Tigo Energy, Inc. The firm is seeking lead plaintiffs and encouraging investors who purchased securities during specified class periods to join the litigation. The lawsuits allege materially false and misleading statements regarding business operations and financial prospects.

The global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions.

Rosen Law Firm is reminding investors in Blaize Holdings, Smartsheet Inc., and DICK'S Sporting Goods of upcoming lead plaintiff deadlines in securities class actions. The lawsuits allege false statements, improper revenue recognition, and undisclosed business practices that caused investor damages.

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) for allegedly making false and misleading statements regarding revenue recognition and announcing transactions with unequipped entities to create an appearance of growth. Investors who purchased Blaize securities between July 17, 2025 and August 13, 2026 have until October 5, 2026 to apply as lead plaintiff.

Goldman Sachs has been a trending stock with shares down 8.6% over the past month. The company is expected to report strong earnings growth of 35.7% for the current fiscal year with revenue growth of 22.9%. Goldman recently beat consensus estimates with a 44.99% EPS surprise and 23.31% revenue surprise. However, the stock carries a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market in the near term, and is valued at par with its peers.

Trio Petroleum Corp acquired 24 oil wells (4 producing, 20 shut-in) from Marlin Resources Ltd in Saskatchewan's Lloydminster region for CDN$800,000 cash plus an underutilized water disposal asset. The acquisition includes 37 BOPD of current production, a planned Cummings multilateral well with CDN$1.2 million development budget, and a CDN$425,000 workover program. The company expects the purchase price per flowing barrel to be discounted compared to market rates for comparable assets.

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) for allegedly making false and misleading statements regarding revenue recognition and announcing transactions with unequipped entities to create an appearance of growth. Investors who purchased Blaize securities between July 17, 2025 and August 13, 2026 have until October 5, 2026 to apply as lead plaintiff.

Rosen Law Firm reminds investors in Blaize Holdings, Inc. (NASDAQ: BZAI) of the October 5, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Blaize made false statements about business transactions, improperly recognized revenue, and misled investors about company growth.

A securities class action lawsuit has been filed against UWM Holdings Corporation for allegedly making materially false and misleading statements regarding its mortgage servicing rights hedging strategy. The lawsuit claims the company deviated from its traditional non-hedging approach, over-hedged in anticipation of the Two Harbors transaction, and created excess hedging risk while making positive statements about its business that lacked reasonable basis. Investors who purchased securities between March 9, 2026 and August 5, 2026 may be eligible for compensation. The lead plaintiff deadline is October 13, 2026.

Rosen Law Firm reminds investors who purchased Blaize Holdings (BZAI) securities between July 18, 2025 and April 28, 2026 of the October 5, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Blaize made false statements about business transactions, improperly recognized revenue, and misled investors about company growth.

Ormat Technologies has been selected by the U.S. Department of Energy for up to $35 million in funding to advance Enhanced Geothermal Systems (EGS) at its Dixie Valley, Nevada project ($25 million) and hydrothermal development at its Cove Fort, Utah project ($9.7 million). The projects will involve partnerships with SLB and the University of Utah to demonstrate engineered reservoirs and enhance understanding of geothermal resources.

Goldman Sachs closed at $959.39, up 1.85%, outperforming the S&P 500's 1.49% gain. However, the stock has declined 9.36% over the past month. The company is expected to report Q3 2026 earnings of $15.37 per share on October 13, representing 25.47% year-over-year growth, with revenue projected at $17.14 billion. Goldman Sachs holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 13.73, trading at a slight premium to its industry average.

Rosen Law Firm has filed class action lawsuits against Doximity, Inc., PROCEPT BioRobotics Corporation, and DNOW Inc. on behalf of investors who suffered losses. The Doximity lawsuit alleges the company overstated its Newsfeed's revenue impact and lost market share to competitors. Investors with losses exceeding $100,000 are encouraged to seek counsel before upcoming deadlines.

Rosen Law Firm reminds investors in DNOW Inc., PROCEPT BioRobotics Corporation, and Doximity Inc. of upcoming deadlines to join securities class action lawsuits. DNOW faces allegations of false statements regarding merger challenges with MRC Global, while similar class actions have been filed against the other companies. Investors must act by specified deadlines to potentially recover damages.

PagSeguro Digital Ltd. (PAGS) declined 3.14% to $9.26 in the latest trading session, underperforming the broader market gains. Despite a 13.27% monthly gain, the company faces a Hold rating with a Zacks Rank of #3. Upcoming earnings are expected to show 13.89% EPS growth and 6.38% revenue growth year-over-year, though consensus estimates have declined 0.6% in the past month. The stock trades at a Forward P/E of 5.77, below the industry average of 12.76.

The Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) is reviewed as a reasonable option for investors seeking small-cap exposure with a smart beta strategy. The fund has gained 16.84% year-to-date and 18.48% over the past year, with a 0.20% expense ratio. However, cheaper alternatives like iShares Core S&P Small-Cap ETF (IJR) with a 0.06% expense ratio are available for cost-conscious investors.

Vanguard Short-Term Treasury ETF (VGSH) and iShares Core 1-5 Year USD Bond ETF (ISTB) offer different approaches to short-term bond investing. VGSH focuses exclusively on U.S. Treasuries with lower volatility and a 0.03% expense ratio, while ISTB provides broader diversification including corporate bonds with a higher 4.3% dividend yield but higher expense ratio of 0.06%. The choice depends on whether investors prioritize stability and lower costs or higher income potential.

Rosen Law Firm announces a securities class action lawsuit against Hyliion Holdings Corp., alleging the company made false and misleading statements regarding its VFG Holdings partnership and commercial pipeline credibility. Investors who purchased HYLN securities between May 12, 2026 and June 23, 2026 may be eligible for compensation. The lead plaintiff deadline is October 27, 2026.

EuroDry (EDRY) emerges as the better investment choice over Global Ship Lease (GSL) in the shipping industry. EDRY has delivered triple-digit share gains over six months, driven by stronger dry-bulk rates and a disciplined fleet renewal strategy. While GSL offers an attractive 5%+ dividend yield and lower valuation, rising fuel costs from Middle East tensions pressure its profitability. EDRY holds a Zacks Rank #1 (Strong Buy) versus GSL's Rank #3 (Hold).

A comparison of UP Fintech Holding Limited (TIGR) and Goldman Sachs (GS) in the Financial - Investment Bank sector reveals that TIGR is the superior value option. Both stocks have a Zacks Rank #2 (Buy) with positive earnings outlooks, but TIGR demonstrates stronger valuation metrics with a forward P/E of 11.55 versus GS's 14.35, a PEG ratio of 0.32 versus 1.00, and a P/B ratio of 1.04 versus 2.62. TIGR earned a Value grade of A compared to GS's C grade.

GSK has agreed to acquire global rights to Chimagen Biosciences' investigational trispecific T-cell engager (TCE) for up to $750 million. The candidate targets two tumor-associated antigens simultaneously and is designed to improve efficacy and tolerability in multiple myeloma treatment, with Phase I studies expected to begin in 2027. This acquisition expands GSK's multiple myeloma portfolio and strengthens its focus on multi-specific T-cell therapies.